TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Pharmarelations AB
Closing information (x1000 NOK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
330,645
|
335,021
|
283,718 |
| Financial expenses |
430
|
437
|
326 |
| Earnings before taxes |
13,280
|
21,999
|
21,881 |
| EBITDA |
12,394
|
21,561
|
22,082 |
| Total assets |
126,658
|
121,974
|
92,896 |
| Current assets |
126,061
|
121,389
|
92,274 |
| Current liabilities |
39,340
|
47,030
|
34,833 |
| Equity capital |
81,872
|
70,042
|
49,723 |
| - share capital |
109
|
107
|
95 |
| Employees (average) |
204
|
227
|
197 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
64.6%
|
57.4%
|
53.5% |
| Turnover per employee |
1,621
|
1,476
|
1,440 |
| Profit as a percentage of turnover |
4.0%
|
6.6%
|
7.7% |
| Return on assets (ROA) |
10.8%
|
18.4%
|
23.9% |
| Current ratio |
320.4%
|
258.1%
|
264.9% |
| Return on equity (ROE) |
16.2%
|
31.4%
|
44.0% |
| Change turnover |
-10,416
|
31,171
|
88,246 |
| Change turnover % |
-3%
|
10%
|
45% |
| Chg. No. of employees |
-23
|
30
|
51 |
| Chg. No. of employees % |
-10%
|
15%
|
35% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.